Back to Learn
TesamorelinGuide2 min read

EGRIFTA WR, EGRIFTA SV, and Compounded Tesamorelin: Formulation Matters

EGRIFTA WR and EGRIFTA SV have different product-specific doses, preparation steps, and storage instructions; the WR label states that they are not substitutable. A compounded tesamorelin preparation is another distinct product question.

By PacificRx editorial team · Published

At a glance

EGRIFTA WR and EGRIFTA SV have different product-specific doses, preparation steps, and storage instructions; the WR label states that they are not substitutable. A compounded tesamorelin preparation is another distinct product question. Follow instructions for the exact prescription rather than transferring a routine between formulations.

  • The same ingredient does not mean interchangeable products.
  • Preparation and storage instructions belong to a formulation.
  • Resolve a changed label with the dispensing pharmacist.
This article is educational and is not medical advice. A licensed clinician must review your medical history before determining whether treatment is appropriate.Read our editorial standards.

Why do WR and SV require separate instructions?

The WR prescribing information explicitly distinguishes its formulation from SV. Differences include the amount and number of vials used in preparation, administration instructions, and storage requirements. Product names therefore carry information beyond the ingredient name.

A person familiar with one presentation should not assume that experience supplies the directions for another. This guide does not provide a preparation recipe or a dose conversion; the current product instructions and pharmacy counseling govern the actual prescription.

Where does a compounded preparation fit?

Compounded drugs do not undergo FDA premarket review for safety, effectiveness, or quality. A compounded tesamorelin preparation is not an FDA-approved generic of EGRIFTA and should not automatically inherit its product instructions or approval status.

Ask why the proposed formulation is appropriate, which evidence applies, who prepares and dispenses it, and how its labeling and written instructions are reconciled. An ingredient name alone cannot answer those questions.

What should happen if the refill looks different?

Compare the product name, formulation, concentration where relevant, label, supplied materials, and instructions. Ask the dispensing pharmacist to explain any change before use and request written clarification if directions conflict.

Keep the current product information with the care plan and tell the prescribing team about a change in presentation. Do not translate one product's directions into another using an online chart or a remembered routine.

Sources